• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性抗原诱导T淋巴细胞分泌一种内切糖苷酶,该酶可降解内皮下细胞外基质的硫酸乙酰肝素部分。

Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix.

作者信息

Fridman R, Lider O, Naparstek Y, Fuks Z, Vlodavsky I, Cohen I R

出版信息

J Cell Physiol. 1987 Jan;130(1):85-92. doi: 10.1002/jcp.1041300113.

DOI:10.1002/jcp.1041300113
PMID:2433294
Abstract

The antigen-mediated induction of heparanase, an endoglycosidase capable of degrading heparan sulfate from the subendothelial extracellular matrix (ECM), was investigated in a rat T lymphocyte cell line reactive against the basic protein (BP) of myelin. We found that nonactivated T lymphocytes could be induced to express heparanase activity following exposure to soluble but not to ECM-bound BP. The induction of heparanase was immunologically specific and independent of the presence of syngeneic or allogeneic antigen presenting cells (APC). However, anti-IA antibodies inhibited heparanase expression. Soluble BP induced secretion of heparanase into the culture medium within minutes, despite inhibition of protein synthesis. Cell lysates of T lymphocytes contained heparanase activity. Thus, T lymphocytes secrete a preformed heparanase following exposure to specific antigen.

摘要

在一种对髓鞘碱性蛋白(BP)有反应的大鼠T淋巴细胞系中,研究了抗原介导的乙酰肝素酶(一种能够从内皮下细胞外基质(ECM)降解硫酸乙酰肝素的内切糖苷酶)的诱导作用。我们发现,未活化的T淋巴细胞在暴露于可溶性BP而非ECM结合的BP后,可被诱导表达乙酰肝素酶活性。乙酰肝素酶的诱导具有免疫特异性,且与同基因或异基因抗原呈递细胞(APC)的存在无关。然而,抗IA抗体可抑制乙酰肝素酶的表达。可溶性BP在数分钟内即可诱导乙酰肝素酶分泌到培养基中,尽管蛋白质合成受到抑制。T淋巴细胞的细胞裂解物含有乙酰肝素酶活性。因此,T淋巴细胞在暴露于特定抗原后会分泌预先形成的乙酰肝素酶。

相似文献

1
Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix.可溶性抗原诱导T淋巴细胞分泌一种内切糖苷酶,该酶可降解内皮下细胞外基质的硫酸乙酰肝素部分。
J Cell Physiol. 1987 Jan;130(1):85-92. doi: 10.1002/jcp.1041300113.
2
Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.小鼠巨噬细胞乙酰肝素酶:抑制作用及其与转移性肿瘤细胞的比较。
J Cell Physiol. 1987 Jan;130(1):77-84. doi: 10.1002/jcp.1041300112.
3
Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.乙酰肝素酶和纤溶酶原激活剂在淋巴瘤细胞介导的内皮下细胞外基质中硫酸乙酰肝素降解中的作用。
J Cell Physiol. 1986 Aug;128(2):299-306. doi: 10.1002/jcp.1041280223.
4
Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.血小板和免疫系统循环细胞中乙酰肝素酶的表达:可能参与细胞渗出和外渗。
Invasion Metastasis. 1992;12(2):112-27.
5
Heparanase activity in cultured endothelial cells.培养的内皮细胞中的乙酰肝素酶活性。
J Cell Physiol. 1991 Aug;148(2):274-80. doi: 10.1002/jcp.1041480213.
6
Differential effects of polysulfated polysaccharide on experimental encephalomyelitis, proliferation of autoimmune T cells, and inhibition of heparanase activity.多硫酸化多糖对实验性脑脊髓炎、自身免疫性T细胞增殖及乙酰肝素酶活性抑制的不同作用
J Autoimmun. 1995 Oct;8(5):741-50. doi: 10.1006/jaut.1995.0055.
7
Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells.高转移性淋巴瘤细胞对内皮细胞下层细胞外基质中硫酸乙酰肝素的顺序降解。
Int J Cancer. 1985 Apr 15;35(4):483-91. doi: 10.1002/ijc.2910350411.
8
Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase.活化的T淋巴细胞产生一种可降解基质的硫酸乙酰肝素内切糖苷酶。
Nature. 1984;310(5974):241-4. doi: 10.1038/310241a0.
9
Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity.肝素对T淋巴细胞乙酰肝素酶的抑制作用可阻止T细胞迁移及T细胞介导的免疫反应。
Eur J Immunol. 1990 Mar;20(3):493-9. doi: 10.1002/eji.1830200306.
10
Differentiating human leukemia cells express heparanase that degrades heparan sulfate in subendothelial extracellular matrix.分化型人类白血病细胞表达硫酸乙酰肝素酶,该酶可降解内皮下细胞外基质中的硫酸乙酰肝素。
Leuk Res. 1988;12(9):711-7. doi: 10.1016/0145-2126(88)90003-3.

引用本文的文献

1
Significant Advancements and Evolutions in Chimeric Antigen Receptor Design.嵌合抗原受体设计的重大进展和演变。
Int J Mol Sci. 2024 Nov 13;25(22):12201. doi: 10.3390/ijms252212201.
2
The Heparanase Regulatory Network in Health and Disease.肝素酶调控网络在健康与疾病中的作用。
Int J Mol Sci. 2021 Oct 14;22(20):11096. doi: 10.3390/ijms222011096.
3
Heparanase and the hallmarks of cancer.乙酰肝素酶与癌症的特征
J Transl Med. 2020 Nov 30;18(1):453. doi: 10.1186/s12967-020-02624-1.
4
Leukocyte Heparanase: A Double-Edged Sword in Tumor Progression.白细胞肝素酶:肿瘤进展中的双刃剑。
Front Oncol. 2019 Apr 29;9:331. doi: 10.3389/fonc.2019.00331. eCollection 2019.
5
Heparan sulfate is a plasma biomarker of acute cellular allograft rejection.硫酸乙酰肝素是急性细胞同种异体移植排斥反应的血浆生物标志物。
PLoS One. 2018 Aug 7;13(8):e0200877. doi: 10.1371/journal.pone.0200877. eCollection 2018.
6
Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology.针对炎症和骨疾病治疗的微生物代谢产物及其衍生物:化学、生物活性与药理学
J Antibiot (Tokyo). 2017 Nov 1. doi: 10.1038/ja.2017.138.
7
Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.乙酰肝素酶对癌症、自噬和炎症的调控:治疗的新机制与靶点
FEBS J. 2017 Jan;284(1):42-55. doi: 10.1111/febs.13932. Epub 2016 Nov 16.
8
Heparan Sulfate Proteoglycan Metabolism and the Fate of Grafted Tissues.硫酸乙酰肝素蛋白聚糖代谢与移植组织的命运
Adv Exp Med Biol. 2015;865:123-40. doi: 10.1007/978-3-319-18603-0_8.
9
Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes.乙酰肝素酶促进CAR重定向T淋巴细胞的肿瘤浸润和抗肿瘤活性。
Nat Med. 2015 May;21(5):524-9. doi: 10.1038/nm.3833. Epub 2015 Apr 13.
10
Expression of a Secreted Fibroblast Growth Factor Binding Protein-1 (FGFBP1) in Angioproliferative Kaposi Sarcoma.分泌型成纤维细胞生长因子结合蛋白-1(FGFBP1)在血管增殖性卡波西肉瘤中的表达
J AIDS Clin Res. 2014 Jun;5(6). doi: 10.4172/2155-6113.1000309.